Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Mayne Pharma Signs 20-Year Exclusive License and Supply Agreement for Novel Oral Contraceptive in the US 2019-10-02 12:01
Clarivate Analytics introduces next-generation pre-clinical drug research platform with Cortellis Drug Discovery Intelligence 2019-10-02 01:39
CapsCanada Expands Growth to New State-of-the-Art Facility 2019-10-01 19:00
Shanghai Pharma Global Standard Stock Incentive Scheme to Push Innovation Refiled for Approval 2019-10-01 04:00
Yuyu Pharma Unveils New Corporate Logo 2019-09-30 21:00
ESMO 2019: CStone presents pooled safety data from the Phase 1b trial of CS1001, demonstrating promising overall safety and tolerability 2019-09-30 18:29
Ascletis Announces Departure of Chief Financial Officer 2019-09-30 16:30
Ascletis Announces Departure of Chief Financial Officer 2019-09-30 16:30
Interleukin 11 Identified as New Therapeutic Target for Idiopathic Pulmonary Fibrosis 2019-09-30 15:00
Adlai Nortye Presents Encouraging Phase 1b Study Data of AN0025 (an Oral EP4 Antagonist) for Locally Advanced Rectal Cancer at ESMO 2019 2019-09-30 13:41
The 10th China (Taizhou) International Medical Expo successfully ended 2019-09-30 13:27
Data From Ascensia Diabetes Care Shows High Accuracy of the CONTOUR®PLUS and CONTOUR®PLUS ONE BGMS in Low Blood Glucose Range and Potential Benefits From Using the CONTOUR®PLUS ONE BGMS With the Health2Sync App 2019-09-30 09:00
Bridge Biotherapeutics Presents Positive Results from Phase 1 Clinical Study of BBT-877 for Idiopathic Pulmonary Fibrosis (IPF) Treatments at the ERS International Congress 2019 2019-09-30 06:00
Kinoxis Therapeutics Awarded NIH HEAL Initiative Grant to Advance KNX100 for the Treatment of Opioid Withdrawal 2019-09-30 05:00
Simcere and JW Pharmaceutical Announce Collaboration and License Agreement for Anti-Gout Drug Candidate URC-102 in China 2019-09-27 18:52
New Data for BAVENCIO® (avelumab) for Advanced Cancers to Be Presented at ESMO 2019 2019-09-27 14:00
New Clarivate Analytics report shows the cost to bring a drug to market has decreased to under $2B for the first time in over five years 2019-09-26 21:00
Thermo Fisher Scientific Expands Clinical Trials Capabilities and Announces Collaboration with Frontier Biotechnologies Inc. 2019-09-26 14:00
OrbusNeich® Announces Japan Approval for COMBO® Plus Coronary Stent 2019-09-26 01:01
Helsinn and Mundipharma China Pharmaceutical jointly announce NMPA's approval of the oral formulation of Akynzeo(R) in China 2019-09-25 12:11
1 328 329 330 331 332 423